NEW YORK & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Today Edgemont Capital Partners, a leading independent investment banking firm providing merger and acquisition advisory services to healthcare companies, announced that it acted as exclusive financial advisor to SCYNEXIS, Inc. in the sale of its contract research and development services business to Avista Pharma Solutions. The deal was announced on July 23. SCYNEXIS, a pharmaceutical company committed to the discovery, development and


| < Prev | Next > |
|---|
